Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 227

1.

Breast cancer survival is associated with telomere length in peripheral blood cells.

Svenson U, Nordfjäll K, Stegmayr B, Manjer J, Nilsson P, Tavelin B, Henriksson R, Lenner P, Roos G.

Cancer Res. 2008 May 15;68(10):3618-23. doi: 10.1158/0008-5472.CAN-07-6497.

2.

Telomere length in peripheral blood predicts survival in clear cell renal cell carcinoma.

Svenson U, Ljungberg B, Roos G.

Cancer Res. 2009 Apr 1;69(7):2896-901. doi: 10.1158/0008-5472.CAN-08-3513. Epub 2009 Mar 24.

3.

Longer relative telomere length in blood from women with sporadic and familial breast cancer compared with healthy controls.

Gramatges MM, Telli ML, Balise R, Ford JM.

Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):605-13. doi: 10.1158/1055-9965.EPI-09-0896.

4.

Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer.

Broberg K, Björk J, Paulsson K, Höglund M, Albin M.

Carcinogenesis. 2005 Jul;26(7):1263-71. Epub 2005 Mar 3.

PMID:
15746160
5.

Telomere dysfunction: a potential cancer predisposition factor.

Wu X, Amos CI, Zhu Y, Zhao H, Grossman BH, Shay JW, Luo S, Hong WK, Spitz MR.

J Natl Cancer Inst. 2003 Aug 20;95(16):1211-8.

PMID:
12928346
6.

Telomere length and the risk of lung cancer.

Jang JS, Choi YY, Lee WK, Choi JE, Cha SI, Kim YJ, Kim CH, Kam S, Jung TH, Park JY.

Cancer Sci. 2008 Jul;99(7):1385-9. doi: 10.1111/j.1349-7006.2008.00831.x. Epub 2008 Apr 29.

7.

Telomere length, cigarette smoking, and bladder cancer risk in men and women.

McGrath M, Wong JY, Michaud D, Hunter DJ, De Vivo I.

Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):815-9.

8.

Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.

Gertler R, Rosenberg R, Stricker D, Friederichs J, Hoos A, Werner M, Ulm K, Holzmann B, Nekarda H, Siewert JR.

J Clin Oncol. 2004 May 15;22(10):1807-14.

PMID:
15143073
9.

Telomere length and telomerase subunits as diagnostic and prognostic biomarkers in Barrett carcinoma.

Gertler R, Doll D, Maak M, Feith M, Rosenberg R.

Cancer. 2008 May 15;112(10):2173-80. doi: 10.1002/cncr.23419.

10.

Short telomeres: a novel potential predictor of relapse in Ewing sarcoma.

Avigad S, Naumov I, Ohali A, Jeison M, Berco GH, Mardoukh J, Stark B, Ash S, Cohen IJ, Meller I, Kollender Y, Issakov J, Yaniv I.

Clin Cancer Res. 2007 Oct 1;13(19):5777-83.

11.

Polymorphisms in telomere-associated genes, breast cancer susceptibility and prognosis.

Varadi V, Brendle A, Brandt A, Johansson R, Enquist K, Henriksson R, Svenson U, Tavelin B, Roos G, Hemminki K, Lenner P, Försti A.

Eur J Cancer. 2009 Nov;45(17):3008-16. doi: 10.1016/j.ejca.2009.08.012. Epub 2009 Sep 18.

PMID:
19766477
12.

Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.

Garcia-Aranda C, de Juan C, Diaz-Lopez A, Sanchez-Pernaute A, Torres AJ, Diaz-Rubio E, Balibrea JL, Benito M, Iniesta P.

Cancer. 2006 Feb 1;106(3):541-51.

13.
14.

Telomere DNA content predicts breast cancer-free survival interval.

Heaphy CM, Baumgartner KB, Bisoffi M, Baumgartner RN, Griffith JK.

Clin Cancer Res. 2007 Dec 1;13(23):7037-43.

15.

Telomere length in the colon declines with age: a relation to colorectal cancer?

O'Sullivan J, Risques RA, Mandelson MT, Chen L, Brentnall TA, Bronner MP, Macmillan MP, Feng Z, Siebert JR, Potter JD, Rabinovitch PS.

Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):573-7.

16.

Telomere shortening and associated chromosomal instability in peripheral blood lymphocytes of patients with Hodgkin's lymphoma prior to any treatment are predictive of second cancers.

M'kacher R, Bennaceur-Griscelli A, Girinsky T, Koscielny S, Delhommeau F, Dossou J, Violot D, Leclercq E, Courtier MH, Béron-Gaillard N, Assaf E, Ribrag V, Bourhis J, Feneux D, Bernheim A, Parmentier C, Carde P.

Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):465-71. Epub 2007 Apr 6.

PMID:
17418962
17.

Plasma and serum levels of tissue inhibitor of metalloproteinases-1 are associated with prognosis in node-negative breast cancer: a prospective study.

Würtz SØ, Møller S, Mouridsen H, Hertel PB, Friis E, Brünner N.

Mol Cell Proteomics. 2008 Feb;7(2):424-30. Epub 2007 Nov 12.

18.

Telomere length in human white blood cells remains constant with age and is shorter in breast cancer patients.

Levy T, Agoulnik I, Atkinson EN, Tong XW, Gause HM, Hasenburg A, Runnebaum IB, Stickeler E, Möbus VJ, Kaplan AL, Kieback DG.

Anticancer Res. 1998 May-Jun;18(3A):1345-9.

PMID:
9673338
19.

Constitutive telomere length and gastric cancer risk: case-control analysis in Chinese Han population.

Liu X, Bao G, Huo T, Wang Z, He X, Dong G.

Cancer Sci. 2009 Jul;100(7):1300-5. doi: 10.1111/j.1349-7006.2009.01169.x. Epub 2009 Apr 30.

20.

Telomere length in peripheral blood leukocytes is associated with risk of colorectal cancer in Chinese population.

Qin Q, Sun J, Yin J, Liu L, Chen J, Zhang Y, Li T, Shi Y, Wei S, Nie S.

PLoS One. 2014 Feb 3;9(2):e88135. doi: 10.1371/journal.pone.0088135. eCollection 2014.

Supplemental Content

Support Center